220 related articles for article (PubMed ID: 9073325)
21. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
[TBL] [Abstract][Full Text] [Related]
22. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.
Murakami M; Hibi M; Nakagawa N; Nakagawa T; Yasukawa K; Yamanishi K; Taga T; Kishimoto T
Science; 1993 Jun; 260(5115):1808-10. PubMed ID: 8511589
[TBL] [Abstract][Full Text] [Related]
23. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
24. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
25. Signaling mechanisms through gp130: a model of the cytokine system.
Hirano T; Nakajima K; Hibi M
Cytokine Growth Factor Rev; 1997 Dec; 8(4):241-52. PubMed ID: 9620640
[TBL] [Abstract][Full Text] [Related]
26. IL-6 cytokine family and signal transduction: a model of the cytokine system.
Hibi M; Nakajima K; Hirano T
J Mol Med (Berl); 1996 Jan; 74(1):1-12. PubMed ID: 8834766
[TBL] [Abstract][Full Text] [Related]
27. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
Modrell B; Liu J; Miller H; Shoyab M
Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
[TBL] [Abstract][Full Text] [Related]
28. gp130 Cytokine family and bone cells.
Heymann D; Rousselle AV
Cytokine; 2000 Oct; 12(10):1455-68. PubMed ID: 11023660
[TBL] [Abstract][Full Text] [Related]
29. Separate regulation of a membrane protein, gp130, present in receptor complex specific for interleukin-6 and other functionally related cytokines.
Falus A; Biró J; Rákász E; Brunner T; Bischoff S
J Mol Recognit; 1994 Dec; 7(4):277-81. PubMed ID: 7734154
[TBL] [Abstract][Full Text] [Related]
30. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction through homo- or heterodimers of gp130.
Kishimoto T
Stem Cells; 1994; 12 Suppl 1():37-44; discussion 44-5. PubMed ID: 7696968
[TBL] [Abstract][Full Text] [Related]
32. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
[TBL] [Abstract][Full Text] [Related]
33. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
35. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
Boulton TG; Zhong Z; Wen Z; Darnell JE; Stahl N; Yancopoulos GD
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6915-9. PubMed ID: 7624343
[TBL] [Abstract][Full Text] [Related]
36. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation.
Pflanz S; Kurth I; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 2000 Dec; 165(12):7042-9. PubMed ID: 11120832
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
39. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.
Lütticken C; Wegenka UM; Yuan J; Buschmann J; Schindler C; Ziemiecki A; Harpur AG; Wilks AF; Yasukawa K; Taga T
Science; 1994 Jan; 263(5143):89-92. PubMed ID: 8272872
[TBL] [Abstract][Full Text] [Related]
40. A new type of cytokine receptor antagonist directly targeting gp130.
Renné C; Kallen KJ; Müllberg J; Jostock T; Grötzinger J; Rose-John S
J Biol Chem; 1998 Oct; 273(42):27213-9. PubMed ID: 9765242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
